JSAS HealthCare, Inc.

JSAS Logo

Author name: jsas_web_admin

Uncategorized

JSASHC Launches Project 1st STOP: A Mobile Initiative to Combat Opioid Use Disorder

By /

In September 2024, JSAS HealthCare was awarded funding through a competitive Request for Proposal process by the New Jersey Department of Human Services, Division of Mental Health and Addiction Services (NJDMHAS) to establish a mobile medication unit (MMU) for Opioid Use Disorder (OUD). We expect Project 1st STOP (Safe Treatment and Overdose Prevention) to be fully operational by April 1, 2025. As supported by the data gathered during the RFP process, JSAS HealthCare (JSASHC’s) Project 1st STOP will target Northern […]

Mobile Substance Use Disorder Treatment Unit
Legislation & Advocacy, News

New Jersey Expands Access to Treatment Through Mobile Units and Travel Reimbursement

By /

New Jersey is making significant strides in expanding access and eliminating transportation barriers to medication-assisted treatment for opioid use disorders. This is being achieved through the implementation of the New Jersey Department of Human Services, Division of Mental Health and Addiction Services’ (NJDMHAS) Medication Assisted Treatment Initiative (MATI) and Travel Reimbursement and Invoicing Program (TRIP).

Legislative advocacy represented by symbols of the judicial process
Legislation & Advocacy, Public Health

NJATOD Advocates for Reconsideration of MOTAA

By /

The New Jersey Association for the Treatment of Opioid Dependence (NJATOD) expresses strong concerns over the Modernizing Opioid Treatment Access Act (MOTAA), advocating for alignment with recent SAMHSA regulations instead. Highlighting risks such as increased overdoses, NJATOD urges a reconsideration of the act, emphasizing the need for safe and regulated treatment expansion through proven methods like mobile services.

Scroll to Top
Loading...